Overview

Study In Asthma Control

Status:
Terminated

Trial end date:
2006-03-28

Target enrollment:

Participant gender:

Summary

This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.

Phase:

Phase 4

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Fluticasone
Salmeterol Xinafoate
Xhance